How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

“I saw in Louisiana a live-oak growing / All alone stood it, and the moss hung down from the branches.” —Walt Whitman, Leaves of Grass, 1860-61 More than 150 years after Whitman wrote those lines, the ...

Recursion Pharmaceuticals, Inc. remains a Sell as pipeline progress, notably REC-4881 in FAP, fails to surpass cheap alternatives like Celebrex. REC-4881's Phase 1/2 data show a median polyp reduction ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Many of the best artificial Christmas trees are on sale for Cyber Week, including our best overall pick, the National Tree Company Douglas Fir. For more deals, check out our roundup of the best Cyber ...

The best artificial Christmas trees dazzle your home without the cleanup and maintenance required of a real tree. They also offer features no live tree can offer: the ability to re-use your tree year ...

Steve Nix is a member of the Society of American Foresters and a former forest resources analyst for the state of Alabama. According to National Wildlife Federation, there are two varieties of Douglas ...